Geographically, the sepsis diagnostics market is segmented into North America, Europe, Asia Pacific, and RoW. Asia Pacific is expected to register the highest growth rate during the forecast period d ue to the high prevalence of sepsis, increasing number of surgical procedures, growing number of clinical studies, and developing healthcare infrastructure in this region.
- Advertising -
Download Sample Papers of Sepsis Diagnostics Market spread across 193 Pages, Profiling 15 Companies and Supported with 130 Tables and 41 Figures is now available at www.rnrmarketresearch.com/contacts…mple?rname=694372 .
The global sepsis diagnostic market is projected to reach USD 613.9 Million by 2023 from USD 396.6 Million in 2018, at a CAGR of 9.1% during forecast period. Factors such as rising prevalence of sepsis across the globe, increasing geriatric population, growing government initiatives for creating sepsis awareness, and high incidence of hospital-acquired infections are expected to drive demand for sepsis diagnosis during study period.
Global Sepsis Diagnostic Market, by Technology
- Molecular Diagnostics
- Flow Cytometry
Global Sepsis Diagnostic Market, by Product
- Blood Culture Media
- Assays & Reagents
The sepsis diagnostic market is categorized into two segments, namely, conventional diagnostics and automated diagnostics.
- Advertising -
The automated diagnostics segment is expected to grow at the highest CAGR from 2018 to 2023. Accurate detection of positive blood cultures, quick turnaround time, and reduced risk of contamination is contributing to the growth of this segment.
More Information on Sepsis Diagnostic Market with Forecast and Company Profiles at www.rnrmarketresearch.com/contacts/694372 .
The sepsis diagnostic market is segmented into microbiology, immunoassays, molecular diagnostics, flow cytometry, microfluidics, and biomarkers. In 2017, the microbiology segment accounted for the largest share of the sepsis diagnostic market.
This share can be attributed to the low cost of microbiology techniques and the wide use of blood culture methods for the diagnosis of sepsis.
- Sepsis diagnostic device manufacturers
- Clinical laboratories
- Hospitals and clinics
- Research institutes and clinical research organizations (CROs)
- Sepsis diagnostic device suppliers and distributors
- Blood culture media manufacturers
- Blood culture media distributors and suppliers
- Market research and consulting firms
The major players of sepsis diagnostics market are bioMérieux (France), T2 Biosystems (US), Luminex (US), Thermo Fisher Scientific (US), Bruker (US), Abbott (US), Roche (Switzerland), Danaher (US), Becton, Dickinson, and Company (US), EKF Diagnostics (UK), Immunexpress (Australia), Response Biomedical (Canada), Axis-Shield Diagnostics (UK), CytoSorbents (US), and Mitsubishi Chemical Europe (Germany).
Report at www.rnrmarketresearch.com/contacts/?rname=694372 .
Sepsis diagnostics market research report has focused on various levels of analysis—market ranking analysis of top players and company profiles, which together comprise and discuss basic views on the competitive landscape, emerging segments of the sepsis diagnostics market, and high-growth regions and their drivers, restraints, challenges, and opportunities.
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, will help firms garner greater market shares.
Category: Market Research Publishers and RetailersCompany about: RnRMarketResearch.com is an online database of market research reports offers in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.
For more information: